发明名称 |
Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds |
摘要 |
A method of treating and/or inhibiting immunological disease states which are associated with a Th1 dominated reaction pattern of the pathological immune response by administering to a patient in need thereof an effective amount of at least one non-endogenous gestagen compound.
|
申请公布号 |
US2005014731(A1) |
申请公布日期 |
2005.01.20 |
申请号 |
US20040855944 |
申请日期 |
2004.05.28 |
申请人 |
SOLVAY PHARMACEUTICALS GMBH |
发明人 |
ALT JEANNETTE;EISELE BERND |
分类号 |
A61K31/00;A61K31/567;A61K31/569;A61K31/57;A61K31/575;A61K31/585;A61P3/10;A61P9/00;A61P17/02;A61P17/06;A61P19/02;A61P25/28;A61P31/04;A61P31/08;A61P31/12;A61P31/18;A61P37/00;A61P37/02;A61P37/06;(IPC1-7):A61K31/56 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|